Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia
Titel:
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia
Auteur:
Short, Nicholas J. Jabbour, Elias Jamison, Trevor Paul, Shilpa Cuglievan, Branko McCall, David Gibson, Amber Jain, Nitin Haddad, Fadi G. Nasr, Lewis F. Marx, Kayleigh R. Rausch, Caitlin Savoy, J. Michael Garris, Rebecca Ravandi, Farhad Kantarjian, Hagop